JP2010509205A5 - - Google Patents

Download PDF

Info

Publication number
JP2010509205A5
JP2010509205A5 JP2009535189A JP2009535189A JP2010509205A5 JP 2010509205 A5 JP2010509205 A5 JP 2010509205A5 JP 2009535189 A JP2009535189 A JP 2009535189A JP 2009535189 A JP2009535189 A JP 2009535189A JP 2010509205 A5 JP2010509205 A5 JP 2010509205A5
Authority
JP
Japan
Prior art keywords
compound
heterocyclyl
alkyl
aryl
cor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009535189A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010509205A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IL2007/001356 external-priority patent/WO2008056356A2/en
Publication of JP2010509205A publication Critical patent/JP2010509205A/ja
Publication of JP2010509205A5 publication Critical patent/JP2010509205A5/ja
Pending legal-status Critical Current

Links

JP2009535189A 2006-11-07 2007-11-07 Ｐｏｓｈ及びｐｏｓｈ−ａｐ阻害剤としてのピリミジン誘導体 Pending JP2010509205A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US85737806P 2006-11-07 2006-11-07
US95983107P 2007-07-17 2007-07-17
PCT/IL2007/001356 WO2008056356A2 (en) 2006-11-07 2007-11-07 Pyrimidine derivatives as posh and posh-ap inhibitors

Publications (2)

Publication Number Publication Date
JP2010509205A JP2010509205A (ja) 2010-03-25
JP2010509205A5 true JP2010509205A5 (enExample) 2010-12-24

Family

ID=39364907

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009535189A Pending JP2010509205A (ja) 2006-11-07 2007-11-07 Ｐｏｓｈ及びｐｏｓｈ−ａｐ阻害剤としてのピリミジン誘導体

Country Status (6)

Country Link
US (2) US8283355B2 (enExample)
EP (1) EP2083826A4 (enExample)
JP (1) JP2010509205A (enExample)
AU (1) AU2007318922C1 (enExample)
CA (1) CA2668859A1 (enExample)
WO (1) WO2008056356A2 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2509601A4 (en) * 2009-11-30 2013-05-29 Proteologics Ltd SMALL PYRIMIDINE DERIVATIVES AND METHOD OF USE THEREOF
WO2013088445A1 (en) * 2011-12-13 2013-06-20 Proteologics Ltd Pyrimidine derivatives for treatment of inflammatory diseases
GB201415688D0 (en) * 2014-09-04 2014-10-22 Univ Edinburgh Method and Systems
CN108025034B (zh) * 2015-07-15 2022-09-30 新加坡科技研究局 乙型肝炎病毒复制的调控
WO2018085208A1 (en) 2016-11-02 2018-05-11 The Research Foundation For The State University Of New York Methods of inhibiting viruses using compositions targeting tsg101-ubiquitin interaction
AU2019297402B2 (en) * 2018-07-05 2024-05-02 Bayer Aktiengesellschaft Substituted thiophenecarboxamides and analogues as antibacterials agents
KR102459858B1 (ko) * 2019-04-02 2022-10-27 연세대학교 산학협력단 신규 화합물 및 이를 유효성분으로 포함하는 호흡기 질환의 예방 또는 치료용 조성물
CN110760597B (zh) * 2019-11-22 2022-08-23 西北农林科技大学 一种检测黄牛ncstn基因拷贝数变异的方法及其应用
TW202527955A (zh) * 2023-11-27 2025-07-16 美商尼坎醫療公司 用於經由泛素蛋白酶體途徑降解週期蛋白依賴性激酶２和週期蛋白依賴性激酶４的含有２，５－取代的嘧啶衍生物的雙功能化合物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5734081A (en) 1994-08-05 1998-03-31 Warner-Lambert Company Arylthio compounds
EP1341817A2 (en) 2000-12-08 2003-09-10 Novo Nordisk A/S Tff peptides
FI116940B (fi) * 2001-07-20 2006-04-13 Juvantia Pharma Ltd Oy Alfa-2B-adrenoseptorivälitteisen sairauden hoitoon tai ehkäisyyn käyttökelpoiset yhdisteet
EP1422228A1 (en) * 2001-08-08 2004-05-26 Takeda Chemical Industries, Ltd. BENZAZEPINE DERIVATIVE, PROCESS FOR PRODUCING THE SAME, AND USE
FR2845382A1 (fr) * 2002-10-02 2004-04-09 Sanofi Synthelabo Derives d'indazolecarboxamides, leur preparation et leur utilisation en therapeutique
EP1673357A2 (en) * 2003-08-08 2006-06-28 Vertex Pharmaceuticals Incorporated Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain
US20050214751A1 (en) * 2004-03-02 2005-09-29 Proteologics, Inc. Inhibition of viral maturation, methods and compositions related thereto
US7671077B2 (en) * 2004-07-19 2010-03-02 Leu-Fen Hou Lin Neuroprotective small organic molecules, compositions and uses related thereto

Similar Documents

Publication Publication Date Title
JP2010509205A5 (enExample)
ES2657687T3 (es) Derivados de pirrolopirimidina para uso en el tratamiento de infecciones virales
AU2010244462B2 (en) Dihydroorotate - dehydrogenase inhibitors as virostatic compounds
RU2015109132A (ru) Пролекарственная форма тенофовира и ее фармацевтические применения
HRP20211224T1 (hr) Derivati pirimidina za liječenje virusnih infekcija
JP2013518107A5 (enExample)
NZ627826A (en) Antiviral combinations involving (3s,11ar)-n-[(2,4-difluorophenyl)methyl]-2,3,5,7,11,11a-hexahydro-6-hydroxy-3-methyl-5,7-dioxo-oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide
NZ597544A (en) Modified 4'-nucleosides as antiviral agents
RU2018136104A (ru) СОЕДИНЕНИЯ, ГЕТЕРОБИЦИКЛО-ЗАМЕЩЕННЫЕ-[1,2,4]ТРИАЗОЛО[1,5- c]ХИНАЗОЛИН-5-АМИНА, ОБЛАДАЮЩИЕ СВОЙСТВАМИ A2А АНТАГОНИСТОВ
RU2012117829A (ru) Фосфорамидатные производные нуклеозидов
TW200630344A (en) Tetracyclic indole derivatives as antiviral agents
JP2009526761A5 (enExample)
RU2017135467A (ru) Комбинированное лечение агонистом толл-подобного рецептора (tlr7) и ингибитором сборки капсида вируса гепатита в
HK1207647A1 (en) 2'-chloro nucleoside analogs for hcv infection
EA201171376A1 (ru) Производные тиено[2,3-b]пиридина в качестве ингибиторов репликации вируса
JP2010523522A5 (enExample)
EA201890236A1 (ru) Полициклические карбамоилпиридоновые соединения и их фармацевтическое применение
RU2018102449A (ru) Производные пиразоло[1,5-a]триазин-4-амина, применимые в терапии
JP2014518266A5 (enExample)
EA202090514A1 (ru) Противовирусное средство против гепатита в
RU2015120478A (ru) Пери-карбинолы
CA2862755A1 (en) Antiviral compounds with a dibenzooxaheterocycle moiety
RU2017103656A (ru) Производные изоиндолинона, полезные в качестве противовирусных средств
US20210228601A1 (en) Broad Spectrum Antiviral and Methods of Use
JP2013224953A5 (enExample)